|
C1ORF128 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.04889996267144E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.36079999993422E-09 |
| Normal-vs-Stage2 |
5.799900E-03 |
| Normal-vs-Stage3 |
1.247100E-04 |
| Normal-vs-Stage4 |
1.317280E-03 |
| Stage1-vs-Stage2 |
6.341000E-01 |
| Stage1-vs-Stage3 |
9.395600E-01 |
| Stage1-vs-Stage4 |
8.296000E-01 |
| Stage2-vs-Stage3 |
7.488800E-01 |
| Stage2-vs-Stage4 |
9.084000E-01 |
| Stage3-vs-Stage4 |
8.836400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.26010005050159E-09 |
| Normal-vs-AfricanAmerican |
3.24039999999304E-06 |
| Normal-vs-Asian |
6.869000E-01 |
| Caucasian-vs-AfricanAmerican |
5.416200E-01 |
| Caucasian-vs-Asian |
1.643800E-01 |
| AfricanAmerican-vs-Asian |
2.383800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.50099996057918E-09 |
| Normal-vs-Female |
2.44299999996311E-06 |
| Male-vs-Female |
4.949000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.636680E-04 |
| Normal-vs-Extreme_Weight |
1.38149999995285E-07 |
| Normal-vs-Obese |
6.32119999677272E-08 |
| Normal-vs-Extreme_Obese |
1.978290E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.423000E-01 |
| Normal_Weight-vs-Obese |
3.308600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.000000E-02 |
| Extreme_Weight-vs-Obese |
3.783200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.006000E-02 |
| Obese-vs-Extreme_Obese |
1.591830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.103800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.05099999814229E-08 |
| Normal-vs-Age(61-80Yrs) |
1.06230000018748E-07 |
| Normal-vs-Age(81-100Yrs) |
1.243540E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.979200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.934400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.813600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.510600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.712600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.316600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.39709999627635E-08 |
| Normal-VS-Type2 PRCC |
5.20509999990537E-07 |
| Normal-VS-KIRP CIMP |
8.258100E-03 |
| Normal-VS-Unclassified PRCC |
5.91279999999639E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.360800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.949600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.505200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.968200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.872200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.211800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99919999999932E-05 |
| Normal-vs-N1 |
2.63389999999308E-06 |
| Normal-vs-N2 |
2.169300E-04 |
| N0-vs-N1 |
5.949400E-01 |
| N0-vs-N2 |
3.144600E-01 |
| N1-vs-N2 |
2.357200E-01 |
|
|
